Progress and Controversies in Oncological Urology - 5: Renal, Bladder and Prostate Cancer
An Update
En savoir plus sur le livre
This is an advanced reference and clinical text documenting the latest advances and current knowledge on all aspects of diagnosing and treating renal, bladder and prostate cancer. It contains 33 original, new chapters by high-level experts in urology, oncology, endocrinology, immunohematology, and pathology from leading medical centers in the United States and Europe. Their contributions provide essential updates on today's most intensely researched and debated issues in renal, bladder and prostate cancer. These include molecular genetics, organ-sparing surgery, tumor nephrectomy, metastatic renal cell carcinoma, gene therapy, optimal strategies for early detection, accuracy of grading, avoiding aggressive treatment when unneeded, advances in radiotherapy, minimal invasive treatment alternatives, endocrine treatment, androgen monotherapy, quality of life issues, new approaches to drug development, intravesical chemotherapy, adjuvant therapy, urinary cytokines as predictors, bladder preservation, orthotopic urinary diversion, systemic treatment, and contemporary approaches for chemotherapy. Massively referenced and fully indexed.
Achat du livre
Progress and Controversies in Oncological Urology - 5: Renal, Bladder and Prostate Cancer, Fritz H. Schröder, Gerald H. Mickisch, Karl H. Kurth
- Langue
- Année de publication
- 1999
- Reliure
- (rigide),
- État du livre
- Bon
- Prix
- 6,09 €
Modes de paiement
Personne n'a encore évalué .
- Titre
- Progress and Controversies in Oncological Urology - 5: Renal, Bladder and Prostate Cancer
- Sous-titre
- An Update
- Langue
- Anglais
- Éditeur
- Parthenon Publishing Group
- Publié
- 1999
- Format
- rigide
- Pages
- 290
- ISBN10
- 1850700818
- ISBN13
- 9781850700814
- Séries
- Mots clés
- États-Unis, Médecine, Oncologie, Urologie, Prostate
- Description
- This is an advanced reference and clinical text documenting the latest advances and current knowledge on all aspects of diagnosing and treating renal, bladder and prostate cancer. It contains 33 original, new chapters by high-level experts in urology, oncology, endocrinology, immunohematology, and pathology from leading medical centers in the United States and Europe. Their contributions provide essential updates on today's most intensely researched and debated issues in renal, bladder and prostate cancer. These include molecular genetics, organ-sparing surgery, tumor nephrectomy, metastatic renal cell carcinoma, gene therapy, optimal strategies for early detection, accuracy of grading, avoiding aggressive treatment when unneeded, advances in radiotherapy, minimal invasive treatment alternatives, endocrine treatment, androgen monotherapy, quality of life issues, new approaches to drug development, intravesical chemotherapy, adjuvant therapy, urinary cytokines as predictors, bladder preservation, orthotopic urinary diversion, systemic treatment, and contemporary approaches for chemotherapy. Massively referenced and fully indexed.